{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:44:13Z","timestamp":1794487453144,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CC2057"],"award-info":[{"award-number":["CC2057"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["CC2057"],"award-info":[{"award-number":["CC2057"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SLFN11 is epigenetically silenced and confers chemoresistance in half of all cancers. In response to replication stress, SLFN11 triggers translation shutdown and p53-independent apoptosis, but how DNA damage activates SLFN11 remains unclear. Here through CRISPR-based screens we implicate SLFN11 as the critical determinant of cisplatin sensitivity in cells lacking primase\u2013polymerase (PrimPol)-mediated repriming. SLFN11 and the downstream integrated stress response uniquely promote cisplatin-driven apoptosis in PrimPol-deficient cells. We demonstrate that replication protein A (RPA) exhaustion and single-stranded DNA exposure trigger SLFN11 activation and cell death when PrimPol is inactivated. We further identify the USP1\u2013WDR48 deubiquitinase complex as a positive modulator of SLFN11 activation in PrimPol-deficient cells, revealing an addiction to the Fanconi anaemia pathway to resolve cisplatin lesions. Finally, we demonstrate that rapid RPA exhaustion on chemical inhibition of DNA polymerase \u03b1 activates SLFN11-dependent cell death. Together, our results implicate RPA exhaustion as a general mechanism to activate SLFN11 in response to heightened replication stress.<\/jats:p>","DOI":"10.1038\/s41556-025-01852-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:02:40Z","timestamp":1767952960000},"page":"240-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-9909","authenticated-orcid":false,"given":"Tyler H.","family":"Stanage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-9889","authenticated-orcid":false,"given":"Sandra","family":"Segura-Bayona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-0553","authenticated-orcid":false,"given":"Aurora I.","family":"Idilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-6834","authenticated-orcid":false,"given":"Simon J.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2\u20139 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1852_CR2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.molcel.2019.04.027","volume":"74","author":"D Cortez","year":"2019","unstructured":"Cortez, D. Replication-coupled DNA repair. Mol. Cell 74, 866\u2013876 (2019).","journal-title":"Mol. Cell"},{"key":"1852_CR3","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 (2022).","journal-title":"Mol. Cell"},{"key":"1852_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcdb.2014.04.035","volume":"30","author":"I Magdalou","year":"2014","unstructured":"Magdalou, I., Lopez, B. S., Pasero, P. & Lambert, S. A. E. The causes of replication stress and their consequences on genome stability and cell fate. Semin. Cell Dev. Biol. 30, 154\u2013164 (2014).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1852_CR5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1126\/science.1083430","volume":"300","author":"L Zou","year":"2003","unstructured":"Zou, L. & Elledge, S. J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542\u20131548 (2003).","journal-title":"Science"},{"key":"1852_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nsmb.3163","volume":"23","author":"M Berti","year":"2016","unstructured":"Berti, M. & Vindigni, A. Replication stress: getting back on track. Nat. Struct. Mol. Biol. 23, 103\u2013109 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1852_CR7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm2450","volume":"9","author":"KA Cimprich","year":"2008","unstructured":"Cimprich, K. A. & Cortez, D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9, 616\u2013627 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1852_CR8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801\u2013817 (2017).","journal-title":"Mol. Cell"},{"key":"1852_CR9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2013.10.043","volume":"155","author":"LI Toledo","year":"2013","unstructured":"Toledo, L. I. et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088\u20131103 (2013).","journal-title":"Cell"},{"key":"1852_CR10","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.celrep.2020.01.067","volume":"30","author":"A Ercilla","year":"2020","unstructured":"Ercilla, A. et al. Physiological tolerance to ssDNA enables strand uncoupling during DNA replication. Cell Rep 30, 2416\u20132429 (2020).","journal-title":"Cell Rep"},{"key":"1852_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41580-020-0257-5","volume":"21","author":"M Berti","year":"2020","unstructured":"Berti, M., Cortez, D. & Lopes, M. The plasticity of DNA replication forks in response to clinically relevant genotoxic stress. Nat. Rev. Mol. Cell Biol. 21, 633\u2013651 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1852_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2013.09.025","volume":"52","author":"S Garc\u00eda-G\u00f3mez","year":"2013","unstructured":"Garc\u00eda-G\u00f3mez, S. et al. PrimPol, an archaic primase\/polymerase operating in human cells. Mol. Cell 52, 541\u2013553 (2013).","journal-title":"Mol. Cell"},{"key":"1852_CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2013.10.035","volume":"52","author":"J Bianchi","year":"2013","unstructured":"Bianchi, J. et al. PrimPol bypasses UV photoproducts during eukaryotic chromosomal DNA replication. Mol. Cell 52, 566\u2013573 (2013).","journal-title":"Mol. Cell"},{"key":"1852_CR14","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1093\/nar\/gkz056","volume":"47","author":"LJ Bailey","year":"2019","unstructured":"Bailey, L. J., Bianchi, J. & Doherty, A. J. PrimPol is required for the maintenance of efficient nuclear and mitochondrial DNA replication in human cells. Nucleic Acids Res. 47, 4026\u20134038 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1852_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384101.2016.1191711","volume":"15","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi, K. et al. Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides. Cell Cycle 15, 1\u201312 (2016).","journal-title":"Cell Cycle"},{"key":"1852_CR16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/embor.2013.159","volume":"14","author":"L Wan","year":"2013","unstructured":"Wan, L. et al. hPrimpol1\/CCDC111 is a human DNA primase-polymerase required for the maintenance of genome integrity. EMBO Rep. 14, 1104\u20131112 (2013).","journal-title":"EMBO Rep"},{"key":"1852_CR17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nsmb.2719","volume":"20","author":"S Mour\u00f3n","year":"2013","unstructured":"Mour\u00f3n, S. et al. Repriming of DNA synthesis at stalled replication forks by human PrimPol. Nat. Struct. Mol. Biol. 20, 1383\u20131389 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1852_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molcel.2015.10.038","volume":"61","author":"D Schiavone","year":"2016","unstructured":"Schiavone, D. et al. PrimPol Is required for replicative tolerance of G Quadruplexes in vertebrate cells. Mol. Cell 61, 161\u2013169 (2016).","journal-title":"Mol. Cell"},{"key":"1852_CR19","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1093\/nar\/gkab176","volume":"49","author":"LJ Bainbridge","year":"2021","unstructured":"Bainbridge, L. J., Teague, R. & Doherty, A. J. Repriming DNA synthesis: an intrinsic restart pathway that maintains efficient genome replication. Nucleic Acids Res. 49, 4831\u20134847 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1852_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2019.10.008","volume":"77","author":"A Quinet","year":"2019","unstructured":"Quinet, A. et al. PRIMPOL-mediated adaptive response suppresses replication fork reversal in BRCA-deficient cells. Mol. Cell 77, 461\u2013474 (2019).","journal-title":"Mol. Cell"},{"key":"1852_CR21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19570-7","volume":"11","author":"AL Piberger","year":"2020","unstructured":"Piberger, A. L. et al. PrimPol-dependent single-stranded gap formation mediates homologous recombination at bulky DNA adducts. Nat. Commun. 11, 5863 (2020).","journal-title":"Nat. Commun."},{"key":"1852_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/nar\/gkad1054","volume":"52","author":"C Mellor","year":"2023","unstructured":"Mellor, C., Nassar, J., \u0160vikovi\u0107, S. & Sale, J. E. PRIMPOL ensures robust handoff between on-the-fly and post-replicative DNA lesion bypass. Nucleic Acids Res. 52, 243\u2013258 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1852_CR23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3724\/abbs.2022165","volume":"55","author":"T Li","year":"2022","unstructured":"Li, T., Tang, L., Kou, H. & Wang, F. PRIMPOL competes with RAD51 to resolve G-quadruplex-induced replication stress via its interaction with RPA. Acta Biochim. Biophys. Sin. 55, 498\u2013507 (2022).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"1852_CR24","doi-asserted-by":"crossref","unstructured":"\u0160vikovi\u0107, S. et al. R-loop formation during S phase is restricted by PrimPol-mediated repriming. EMBO J. 38, e99793 (2019).","DOI":"10.15252\/embj.201899793"},{"key":"1852_CR25","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Acosta, D. et al. PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. EMBO J. https:\/\/doi.org\/10.15252\/embj.2020106355 (2021).","DOI":"10.15252\/embj.2020106355"},{"key":"1852_CR26","doi-asserted-by":"crossref","first-page":"103787","DOI":"10.1016\/j.dnarep.2024.103787","volume":"145","author":"M Washif","year":"2024","unstructured":"Washif, M., Kawasumi, R. & Hirota, K. PrimPol-mediated repriming elicits gap-filling by template switching and promotes cellular tolerance to cidofovir. DNA Repair 145, 103787 (2024).","journal-title":"DNA Repair"},{"key":"1852_CR27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk2771","volume":"10","author":"AS Kawale","year":"2024","unstructured":"Kawale, A. S. et al. APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Sci. Adv. 10, eadk2771 (2024).","journal-title":"Sci. Adv."},{"key":"1852_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari, S. & Tchounwou, P. B. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol. 740, 364\u2013378 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"1852_CR29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi, R., Sarangi, P. & D\u2019Andrea, A. D. The Fanconi anaemia pathway: new players and new functions. Nat. Rev. Mol. Cell Biol. 17, 337\u2013349 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1852_CR30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nsmb1252","volume":"14","author":"AE Sims","year":"2007","unstructured":"Sims, A. E. et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14, 564\u2013567 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1852_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2007.03.009","volume":"129","author":"A Smogorzewska","year":"2007","unstructured":"Smogorzewska, A. et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289\u2013301 (2007).","journal-title":"Cell"},{"key":"1852_CR32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.molcel.2007.09.031","volume":"28","author":"MA Cohn","year":"2007","unstructured":"Cohn, M. A. et al. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28, 786\u2013797 (2007).","journal-title":"Mol. Cell"},{"key":"1852_CR33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","volume":"182","author":"M Olivieri","year":"2020","unstructured":"Olivieri, M. et al. A genetic map of the response to DNA damage in human cells. Cell 182, 481\u2013496 (2020).","journal-title":"Cell"},{"key":"1852_CR34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"D-W Shen","year":"2012","unstructured":"Shen, D.-W., Pouliot, L. M., Hall, M. D., Gottesman, M. M. & Sibley, D. R. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol. Rev. 64, 706\u2013721 (2012).","journal-title":"Pharmacol. Rev."},{"key":"1852_CR35","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.3390\/ijms20174136","volume":"20","author":"S-H Chen","year":"2019","unstructured":"Chen, S.-H. & Chang, J.-Y. New Insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment. Int. J. Mol. Sci. 20, 4136 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1852_CR36","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.1205943109","volume":"109","author":"G Zoppoli","year":"2012","unstructured":"Zoppoli, G. et al. Putative DNA\/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc. Natl Acad. Sci. USA 109, 15030\u201315035 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1852_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2018.01.012","volume":"69","author":"J Murai","year":"2018","unstructured":"Murai, J. et al. SLFN11 blocks stressed replication forks independently of ATR. Mol. Cell 69, 371\u2013384 (2018).","journal-title":"Mol. Cell"},{"key":"1852_CR38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.adh7950","volume":"384","author":"NJ Boon","year":"2024","unstructured":"Boon, N. J. et al. DNA damage induces p53-independent apoptosis through ribosome stalling. Science 384, 785\u2013792 (2024).","journal-title":"Science"},{"key":"1852_CR39","doi-asserted-by":"publisher","unstructured":"Ogawa, A. et al. SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis. Mol. Cell https:\/\/doi.org\/10.1016\/j.molcel.2025.01.008 (2025).","DOI":"10.1016\/j.molcel.2025.01.008"},{"key":"1852_CR40","doi-asserted-by":"crossref","first-page":"28575","DOI":"10.18632\/oncotarget.15338","volume":"8","author":"CA Stewart","year":"2017","unstructured":"Stewart, C. A. et al. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer. Oncotarget 8, 28575\u201328587 (2017).","journal-title":"Oncotarget"},{"key":"1852_CR41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/epi-2017-0019","volume":"9","author":"T He","year":"2017","unstructured":"He, T. et al. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer. Epigenomics 9, 849\u2013862 (2017).","journal-title":"Epigenomics"},{"key":"1852_CR42","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.18632\/oncotarget.6413","volume":"7","author":"V Nogales","year":"2015","unstructured":"Nogales, V. et al. Epigenetic inactivation of the putative DNA\/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs. Oncotarget 7, 3084\u20133097 (2015).","journal-title":"Oncotarget"},{"key":"1852_CR43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","volume":"201","author":"J Murai","year":"2019","unstructured":"Murai, J., Thomas, A., Miettinen, M. & Pommier, Y. Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies. Pharmacol. Ther. 201, 94\u2013102 (2019).","journal-title":"Pharmacol. Ther."},{"key":"1852_CR44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 (2017).","journal-title":"Cell"},{"key":"1852_CR45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.15252\/embr.201540964","volume":"17","author":"Y Mu","year":"2016","unstructured":"Mu, Y. et al. SLFN11 inhibits checkpoint maintenance and homologous recombination repair. EMBO Rep. 17, 94\u2013109 (2016).","journal-title":"EMBO Rep."},{"key":"1852_CR46","volume":"118","author":"U Jo","year":"2021","unstructured":"Jo, U. et al. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR\/CHK1 inhibitors. Proc. Natl Acad. Sci. USA 118, e2015654118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1852_CR47","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.celrep.2020.02.117","volume":"30","author":"J Murai","year":"2020","unstructured":"Murai, J. et al. Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress. Cell Rep. 30, 4137\u20134151 (2020).","journal-title":"Cell Rep."},{"key":"1852_CR48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41594-018-0142-5","volume":"25","author":"M Li","year":"2018","unstructured":"Li, M. et al. DNA damage-Induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs. Nat. Struct. Mol. Biol. 25, 1047\u20131058 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1852_CR49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature11433","volume":"491","author":"M Li","year":"2012","unstructured":"Li, M. et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491, 125\u2013128 (2012).","journal-title":"Nature"},{"key":"1852_CR50","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"1852_CR51","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.18632\/oncotarget.2210","volume":"5","author":"W-P Su","year":"2014","unstructured":"Su, W.-P. et al. Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma. Oncotarget 5, 6323\u20136337 (2014).","journal-title":"Oncotarget"},{"key":"1852_CR52","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1074\/jbc.M117.792192","volume":"292","author":"MA Sanders","year":"2017","unstructured":"Sanders, M. A., Haynes, B., Nangia-Makker, P., Polin, L. A. & Shekhar, M. P. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs. J. Biol. Chem. 292, 10347\u201310363 (2017).","journal-title":"J. Biol. Chem."},{"key":"1852_CR53","volume":"10","author":"YS Michaels","year":"2019","unstructured":"Michaels, Y. S. et al. Precise tuning of gene expression levels in mammalian cells. Nat. Commun. 10, 818 (2019).","journal-title":"Nat. Commun."},{"key":"1852_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41421-021-00332-8","volume":"7","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. Selective and competitive functions of the AAR and UPR pathways in stress-induced angiogenesis. Cell Discov. 7, 98 (2021).","journal-title":"Cell Discov."},{"key":"1852_CR55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/cb100428c","volume":"6","author":"F Huang","year":"2011","unstructured":"Huang, F. et al. Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening. ACS Chem. Biol. 6, 628\u2013635 (2011).","journal-title":"ACS Chem. Biol."},{"key":"1852_CR56","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","volume":"275","author":"EP Rogakou","year":"2000","unstructured":"Rogakou, E. P., Nieves-Neira, W., Boon, C., Pommier, Y. & Bonner, W. M. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139*. J. Biol. Chem. 275, 9390\u20139395 (2000).","journal-title":"J. Biol. Chem."},{"key":"1852_CR57","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.bmcl.2004.09.060","volume":"14","author":"JJJ Leahy","year":"2004","unstructured":"Leahy, J. J. J. et al. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg. Med. Chem. Lett. 14, 6083\u20136087 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1852_CR58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nchembio.1455","volume":"10","author":"Q Liang","year":"2014","unstructured":"Liang, Q. et al. A selective USP1\u2013UAF1 inhibitor links deubiquitination to DNA damage responses. Nat. Chem. Biol. 10, 298\u2013304 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"1852_CR59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","volume":"17","author":"SMB Nijman","year":"2005","unstructured":"Nijman, S. M. B. et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 17, 331\u2013339 (2005).","journal-title":"Mol Cell"},{"key":"1852_CR60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ncb1378","volume":"8","author":"TT Huang","year":"2006","unstructured":"Huang, T. T. et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8, 341\u2013347 (2006).","journal-title":"Nat. Cell Biol."},{"key":"1852_CR61","first-page":"39","volume":"8","author":"R Abdel-Samad","year":"2017","unstructured":"Abdel-Samad, R. et al. Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase \u03b1. Am. J. Cancer Res. 8, 39\u201355 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"1852_CR62","doi-asserted-by":"crossref","unstructured":"Costa-Mattioli, M. & Walter, P. The integrated stress response: from mechanism to disease. Science 368, eaat5314 (2020).","DOI":"10.1126\/science.aat5314"},{"key":"1852_CR63","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep 17, 1374\u20131395 (2016).","journal-title":"EMBO Rep"},{"key":"1852_CR64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33123-0","volume":"13","author":"FJ Metzner","year":"2022","unstructured":"Metzner, F. J. et al. Mechanistic understanding of human SLFN11. Nat. Commun. 13, 5464 (2022).","journal-title":"Nat. Commun."},{"key":"1852_CR65","volume":"9","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. Schlafen 11 triggers innate immune responses through its ribonuclease activity upon detection of single-stranded DNA. Sci. Immunol. 9, eadj5465 (2024).","journal-title":"Sci. Immunol."},{"key":"1852_CR66","doi-asserted-by":"publisher","unstructured":"Hewitt, G. et al. Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD. Mol. Cell https:\/\/doi.org\/10.1016\/j.molcel.2020.12.006 (2020).","DOI":"10.1016\/j.molcel.2020.12.006"},{"key":"1852_CR67","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson, K. R. et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).","journal-title":"Nat. Commun."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01852-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:40:41Z","timestamp":1771598441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01852-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1038\/s41556-025-01852-1","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.B. is co-founder and shareholder in Artios Pharma Limited, unrelated to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}